We use cookies to help provide you with the best possible online experience. Please read our Privacy Policy for information about which cookies we use and what information we collect on our site. By continuing to use this site, you agree that we may store and access cookies on your device.
Tandem is testing a system comprising its t:slim X2 insulin pump, its predictive low-glucose suspend algorithm and a Dexcom continuous glucose monitor in patients with Type 1 diabetes.